Last $59.30 USD
Change Today -0.30 / -0.50%
Volume 2.4M
CFN On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

carefusion corp (CFN) Snapshot

Open
$59.47
Previous Close
$59.60
Day High
$59.56
Day Low
$59.26
52 Week High
01/23/15 - $60.08
52 Week Low
04/15/14 - $37.76
Market Cap
12.1B
Average Volume 10 Days
2.1M
EPS TTM
$2.14
Shares Outstanding
204.2M
EX-Date
--
P/E TM
27.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for CAREFUSION CORP (CFN)

carefusion corp (CFN) Related Businessweek News

View More BusinessWeek News

carefusion corp (CFN) Details

CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, and respiratory care. The company operates through two segments, Medical Systems and Procedural Solutions. Its primary product brands include Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela, and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite, and Texium needle-free IV infusion valves, and administration sets and accessories; PleurX, Achieve, and Temno interventional specialty products; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Jaeger and SensorMedics cardiopulmonary diagnostic equipment; Vital Signs single-use consumables for respiratory care and anesthesiology; and MedMined data mining surveillance software and analytics tools to help hospitals identify adverse drug events and healthcare associated infections. The company also offers CareFusion branded ventilation system; and Guardrails, a software application. Its primary customers include hospitals, ambulatory surgical centers, clinics, long-term care facilities, and physician offices in the United States. The company also sells its products to hospitals in approximately 130 countries. It offers its products directly to group purchasing organizations, as well as through integrated delivery networks, wholesalers, and distributors. CareFusion Corporation was incorporated in 2009 and is headquartered in San Diego, California.

16,000 Employees
Last Reported Date: 08/11/14
Founded in 2009

carefusion corp (CFN) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.2M
Chief Financial Officer
Total Annual Compensation: $559.6K
President of Medical Systems
Total Annual Compensation: $498.0K
Executive Vice President, General Counsel and...
Total Annual Compensation: $492.9K
Executive Vice President of EMEA/ANZ Commerci...
Total Annual Compensation: $400.0K
Compensation as of Fiscal Year 2014.

carefusion corp (CFN) Key Developments

CareFusion Corporation Expands Capabilities of Medication Management Solutions

CareFusion Corporation has expanded capabilities of its enterprise-wide medication management solutions for use in hospitals and outpatient settings. The company also introduced new products to support greater transparency to a patient's medication adherence before and after receiving care in a hospital. It has less than 50% of the capacity of a Pyxis MedStation ES system, but provides the same security and access to critical medications closer to patients. The Pyxis Mini system leverages the existing Pyxis ES platform, using the same server, CUBIE pockets, inventory management and data systems as other technologies built on the Pyxis ES platform. This enables Pyxis ES customers to leverage their investment in one platform to have centralized medication management across all of their hospitals, ambulatory and long-term care settings. To date, the Pyxis ES platform has been installed in more than 280 hospitals and health systems. To support medication adherence, the company announced a collaboration with Health Care Systems to enable new capabilities for CareFusion's MedMined Surveillance Advisor to provide hospitals with a list of a patient's medication regimen over the past year upon admission. The reports would help clinicians reconcile a patient's current medications with any new medications needed during his or her hospitalization. In addition, MedMined Surveillance Advisor also has the ability to provide an alert to hospital clinicians if patients do not fill a new prescription within a set period after discharge. Clinicians can select an adherence window between two and 30 days after discharge to receive a notification. This capability will help clinicians know if patients are following their instructions for the prescribed medications needed after the patient leaves the hospital. CareFusion Corporation, also announced an agreement with Medacist to further extend the company's commitment to detect and deter diversion. Under the agreement, CareFusion customers who use the company's Knowledge Portal for Dispensing will be able to run RxAuditor diversion software. The company also demonstrated new technology that can potentially help reduce hospital re-admissions by simplifying a patient's prescribed medication regimen as they transition home. More than 30% of patients don't fill their medication prescriptions, and more than half of patients do not take their medications as prescribed. The new Rowa Dose system takes patient-specific prescriptions of multiple medications and creates dose-specific packages to support medication adherence. Each dose (e.g. morning, afternoon and night) of a patient's medications would be contained in a package(s) that designate the date and time they should be taken. Prior to discharge, a clinician would provide the patient-specific dosages and explain that one pouch always corresponds to one administration time, which is designed to help improve medication use at home. To support safe and efficient infused medication delivery, CareFusion highlighted two new aspects of its offering to extend beyond its industry-leading interoperability capabilities.

Carefusion Corporation and Medacist Solutions Group, LLC Sign Agreement to Collaborate to Detect and Deter Drug Diversion

CareFusion Corporation and Medacist Solutions Group, LLC have signed an agreement to collaborate to detect and deter drug diversion. Under the agreement, CareFusion customers who use the company's Knowledge Portal for Dispensing will be able to run the full version of RxAuditor diversion software. RxAuditor is recognized as the leading medication diversion software in the industry. This collaboration fits well with data and analytics strategy to take medication usage intelligence and bring additional insight and value to customers. RxAuditor software is the only US patented methodology that evaluates key metrics such as controlled substance dispenses, controlled substance discrepancies, medication overrides, waste transactions, cancelled transactions, stock-outs, refills and inventory shrinkage. The reports identify individuals who dispense medication outside of statistically significant parameters of all other users on a hospital's or integrated delivery network's automated dispensing cabinets. These easy-to-use and accurate reports include assurance metrics that enable pharmacy managers to make an informed decision regarding internal audits to confirm or rule-out potential diversion.

CareFusion Corporation(NYSE:CFN) dropped from S&P 500 Value Index

CareFusion Corporation(NYSE:CFN) dropped from S&P 500 Value Index

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CFN:US $59.30 USD -0.30

CFN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $171.03 USD -5.91
Edwards Lifesciences Corp $125.35 USD -3.93
Endo International PLC $79.61 USD -2.03
Terumo Corp ¥2,941 JPY +35.00
Varian Medical Systems Inc $92.56 USD -1.48
View Industry Companies
 

Industry Analysis

CFN

Industry Average

Valuation CFN Industry Range
Price/Earnings 30.1x
Price/Sales 3.1x
Price/Book 2.3x
Price/Cash Flow 29.2x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAREFUSION CORP, please visit www.carefusion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.